IPOS rejects Merck KGaA’s Pfizer trademark challenge
IPOS dismissed Merck KGaA’s opposition to Pfizer’s “ABRYSVO” vaccine trademark, ruling the two brands overall dissimilar despite shared circular logos. Singapore’s Intellectual Property Office (IPOS) has dismissed a trademark opposition filed by German drugmaker Merck KGaA against Pfizer’s “ABRYSVO” vaccine trademark, ruling the two brands are overall dissimilar despite both featuring circular logos. Pfizer’s trademark
IPOS rejects Merck KGaA’s Pfizer trademark challenge Read More »